Literature DB >> 21482954

Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?

Kerstin Hellwig, Ralf Gold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21482954     DOI： 10.1212/WNL.0b013e318210e5d0

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.

Authors:  Michael Kaufman; Bruce A C Cree; Jerome De Sèze; Robert J Fox; Ralf Gold; Hans-Peter Hartung; Douglas Jeffery; Ludwig Kappos; Xavier Montalbán; Bianca Weinstock-Guttman; Barry Ticho; Petra Duda; Amy Pace; Denise Campagnolo
Journal:  J Neurol       Date:  2014-11-09       Impact factor: 4.849

Review 2.  Treatment of Women with Multiple Sclerosis Planning Pregnancy.

Authors:  Kristen M Krysko; Riley Bove; Ruth Dobson; Vilija Jokubaitis; Kerstin Hellwig
Journal:  Curr Treat Options Neurol       Date:  2021-03-30       Impact factor: 3.598

3.  Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy.

Authors:  Kerstin Hellwig; Marianne Tokic; Sandra Thiel; Nina Esters; Charlotte Spicher; Nina Timmesfeld; Andrea I Ciplea; Ralf Gold; Annette Langer-Gould
Journal:  JAMA Netw Open       Date:  2022-01-04

4.  The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results.

Authors:  Sandra Thiel; Andrea I Ciplea; Ralf Gold; Kerstin Hellwig
Journal:  Ther Adv Neurol Disord       Date:  2021-11-22       Impact factor: 6.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.